The Methylation Test That Decides Brain Cancer Treatment Faces a Reckoning
A new Mayo Clinic review in the Journal of Neuro-Oncology examines how MGMT promoter methylation guides brain tumor treatment, why ...
A new Mayo Clinic review in the Journal of Neuro-Oncology examines how MGMT promoter methylation guides brain tumor treatment, why ...
A new computational framework called CSI-TME infers prognostic interactions between cell states in the tumor microenvironment from bulk RNA-seq data, ...
A German study of 121 patients finds that amino acid tracer uptake on preoperative FET PET is independently associated with ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine